Investor Advisory Board
- Mark Booth
Senior Vice President, General Manager Specialty Business Unit, Depomed
- Sach Chitnis
Managing Partner, Jump Capital
- David Dorsey
Senior Associate, Osage University Partners
- Steve Elms
Managing Partner, Aisling Capital
- David Flores
President & CEO, BioCentury
- Valerie Friedman
Principal, Bracebridge Capital, LLC
- Marc-Henri Galletti
Managing Director, Longitude Capital
- Tassos Gianakakos
CEO, MyoKardia, Inc.
- Winton Gibbons
Independent Management Consultant, Past President & CEO, Siloam Biosciences
- Arthur Holden
Chairman and CEO, Pharmaceutical Biomedical Research Consortium, Ltd., iSAEC Consortium
- Adam Koopersmith
Partner, Pritzker Group Venture Capital
- Michael Liang
Partner, RW Baird
- Scott Minick
Partner, ARCH Venture Partners
- Evan Norton
General Partner, Accelmed
- Norbert Riedel, Ph.D.
President and CEO, Aptinyx, Inc.
- Peter Shagory
Executive VP, Strategy & Corporate Development, CONMED
- Geeta Vemuri
Managing Partner, Agent Capital
- Sona Wang
Managing Director, Ceres Venture Fund
- Dan Watkins
Managing Director, DFJ Mercury